Prospective payment and infection control.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003363:Cost Control; D003428:Cross Infection / Q000191:economics / Q000517:prevention & control*; D003953:Diagnosis-Related Groups; D006801:Humans; D007902:Length of Stay / Q000191:economics; D011292:Premedication; D011445:Prospective Payment System / Q000191:economics*; D012051:Reimbursement Mechanisms / Q000191:economics*
D000900:Anti-Bacterial Agents